Adjuvant treatment in high-risk breast cancer

被引：0
|
作者：
Mansi, JL
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 1996年 / 56卷 / 2-3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [31] Role of Adjuvant Treatment in High-risk Patients Following Resection for Gallbladder Cancer
    Park, Younghee
    Kim, Kiryun
    Park, Hae Jin
    Chun, Ha-Jung
    Choi, Dongho
    Kim, Kyubo
    IN VIVO, 2022, 36 (02): : 961 - 968
  • [32] Radiation therapy versus chemoradiation as adjuvant treatment in high-risk endometrial cancer
    Fumagalli, Ingrid
    Leblanc, Eric
    Nickers, Philippe
    BULLETIN DU CANCER, 2012, 99 (01) : 79 - 83
  • [33] TREATMENT FAILURE IN HIGH-RISK HEAD AND NECK CANCER TREATED WITH ADJUVANT CHEMORADIATION
    Torres, S.
    Marques, M. T.
    Ferreira, M.
    Sargento, I.
    Netto, E.
    Oliveira, J.
    Roldao, M.
    Moreira, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 345 - 346
  • [34] 5-DRUG ADJUVANT CHEMOTHERAPY IN HIGH-RISK PATIENTS WITH BREAST-CANCER
    CAREY, RW
    KAUFMAN, S
    SOHIER, WD
    KELLEY, RM
    LEW, R
    HALPERN, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 404 - 404
  • [35] Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients
    Baldini, E
    Tibaldi, C
    Lencioni, M
    Giannessi, P
    Evangelista, G
    Roncella, M
    Spinelli, C
    Meucci, C
    daPrato, M
    Conte, P
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (02): : 169 - 172
  • [36] REEVALUATION OF THE INDICATIONS OF ADJUVANT HORMONOTHERAPY IN HIGH-RISK PRIMARY BREAST-CANCER PATIENTS
    MARTIN, PM
    ROMAIN, S
    SPYRATOS, F
    SPITALIER, JM
    AYME, Y
    BRANDONE, H
    BRESSAC, C
    HANS, D
    JACQUEMIER, J
    HACENE, K
    BRUNET, M
    AMALRIC, R
    BULLETIN DU CANCER, 1991, 78 (08) : 709 - 723
  • [37] A pilot study of adjuvant bevacizumab after neoadjuvant chemotherapy for high-risk breast cancer
    Mayer, E. L.
    Miller, K. D.
    Rugo, H. S.
    Peppercorn, J. M.
    Carey, L. A.
    Ryabin, N.
    Winer, E. P.
    Burstein, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] SODIUM DITIOCARB AS ADJUVANT IMMUNOTHERAPY FOR HIGH-RISK BREAST-CANCER - A RANDOMIZED STUDY
    DUFOUR, P
    LANG, JM
    GIRON, C
    DUCLOS, B
    HAEHNEL, P
    JAECK, D
    JUNG, JM
    OBERLING, F
    BIOTHERAPY, 1993, 6 (01) : 9 - 12
  • [39] Randomized Trial of Adjuvant Zoledronic Acid in Postmenopausal Women With High-Risk Breast Cancer
    Leal, Ticiana
    Tevaarwerk, Amye
    Love, Richard
    Stewart, James
    Binkley, Neil
    Eickhoff, Jens
    Parrot, Benjamin
    Mulkerin, Daniel
    CLINICAL BREAST CANCER, 2010, 10 (06) : 471 - 476
  • [40] Breast cancer: The high-risk mutations
    Brody, LC
    Biesecker, BB
    HOSPITAL PRACTICE, 1997, 32 (10): : 59 - &
12345